Kezar Life Sciences (NASDAQ:KZR) Price Target Cut to $7.00 by Analysts at HC Wainwright
Kezar Life Sciences (NASDAQ:KZR – Free Report) had its price target trimmed by HC Wainwright from $20.00 to $7.00 in a report issued on Monday, Benzinga reports. The firm currently has a buy rating on the stock. Kezar Life Sciences Price Performance KZR stock opened at $0.66 on Monday. Kezar Life Sciences has a 1 […]
More Stories
Global Trade Is Not Ending — It Is Being Reshaped by Geopolitical Competition
Seaports and container terminals remain essential to international commerce, connecting manufacturers, suppliers and consumers across global markets. Photo: Jonathan Thacker...
The AI Investment Boom: Who Will Capture the Economic Benefits?
Data centres provide the computing infrastructure that supports artificial intelligence, cloud services and the digital economy. Photo: Helpameout / Wikimedia...
How to Recover a Disabled Instagram Account? Tips and Process
Losing access to your personal or business Instagram account can disrupt personal connections, professional outreach, or years of memories. Instagram...
How Payment Processing Fees Affect Ecommerce Profit Margins
Card fees take a larger share of an online store’s profit than its revenue line suggests. Publicly traded general retailers...
Ukraine, Russia and Europe: Why the Future of European Security Is at a Turning Point
European diplomacy faces important questions about security, peace and international cooperation. The war in Ukraine continues to shape Europe's political...
COP31: Can World Leaders Turn Climate Promises into Real Action?
Renewable energy investment is central to the international effort to reduce greenhouse gas emissions. Climate change has become one of...
